Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Bader I Alshamsan"'
Autor:
Tusneem Elhassan, Aisha Alshibany, Jean Paul Atallah, Mahmoud A. Elshenawy, Ahmad Badran, Fatma Maraiki, Bader I Alshamsan
Publikováno v:
Cancer Management and Research
Bader Alshamsan, 1, 2 Ahmad Badran, 1, 3 Aisha Alshibany, 1 Fatma Maraiki, 1 Mahmoud A Elshenawy, 1, 4 Tusneem Elhassan, 1 Jean Paul Atallah 1 1Medical Oncology, Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arab
Autor:
Jean Paul Atallah, Bader I Alshamsan
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 3, Pp 1227-1231 (2020)
Case Reports in Oncology, Vol 13, Iss 3, Pp 1227-1231 (2020)
We present the case of a 26-year-old woman living at a high altitude diagnosed initially with nonfamilial and nonsecretory localized carotid body tumor managed with surgery, which developed into a recurrent metastatic tumor treated with cyclophospham
Autor:
Amgad Shahin Mohamed, Tusneem Elhassan, Fahed A Almugbel, Ayman Omar, Hamed Alhussainia, Hanan Alharthy, Hazem Abdullah Alotaibi, Sharifa Al-Farsi, Bader I Alshamsan, Heba Aly Ateya, Naela Agha, Hany Salem
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
BMC Cancer
BMC Cancer
Purpose BRCA gene mutations (BRCAm) have an impact on patients’ characteristics and clinical outcomes of ovarian cancer (OC). The frequency and patterns of BRCAm vary among countries and ethnicities. There are limited data from Saudi Arabia (SA); t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ed8484cc52516c9e85993d86943847
https://doi.org/10.21203/rs.3.rs-126544/v2
https://doi.org/10.21203/rs.3.rs-126544/v2
Autor:
Mahmoud A. Elshenawy, Ahmed Badran, Bader I Alshamsan, Amgad Shaheen, Ali Aljubran, Mohamed Aseafan
Publikováno v:
Journal of Clinical Oncology. 39:e16277-e16277
e16277 Background: Small bowel adenocarcinoma (SBA) is a rare disease. We aim to describe patient's characteristics and clinical outcomes among Saudi patients. Methods: All patients with SBA diagnosed between 2007 - 2020 were reviewed. Logistic regre
Autor:
Adher Al-Sayed, Mahmoud A. Elshenawy, Dahish Ajarim, Ahmed Badran, Kausar Suleman, Taher Al-Tweigeri, Aisha Alshibany, Bader I Alshamsan
Publikováno v:
Journal of Clinical Oncology. 39:e12534-e12534
e12534 Background: Metaplastic breast cancer (MPBC) accounts for less than 1% of all breast cancer subtypes. Methods: Patients diagnosed with MPBC between 2001 are 2018 were reviewed. Disease characteristics, progression-free survival (PFS), and over
Autor:
Rawan K. Matar, Sami Khairy, Bader I Alshamsan, Saleh Alsaleh, Salah Baz, Khalid O. Alahmedi, Hindi Al-Hindi
Publikováno v:
Epilepsy and Behavior Case Reports, Vol 8, Iss C, Pp 100-104 (2017)
Epilepsy & Behavior Case Reports
Epilepsy & Behavior Case Reports
Primary Angiitis of the central nervous system is a rare and poorly understood variant of vasculitis. We narrate a case of a 46-year-old male who presented with new onset refractory status epilepticus mimicking autoimmune encephalitis. In this case w
Autor:
T. Elhassan, F. Maraiki, J.P. Atallah, Mahmoud A. Elshenawy, Bader I Alshamsan, Ahmed Badran, A. Alshibany
Publikováno v:
Annals of Oncology. 31:S987
Background Pazopanib is approved for use after the failure of chemotherapy for soft tissue sarcoma. We aimed to evaluate the clinical outcome and tolerability in a real-world setting. Methods Patients treated between June 2015 and August 2019 were re
Autor:
Dahish Ajarim, T. Elhassan, Taher Al-Tweigeri, Kausar Suleman, N. Fahmy, Bader I Alshamsan, Ahmed Badran, Adher Al-Sayed, Mahmoud A. Elshenawy, M.J. Aseafan
Publikováno v:
Annals of Oncology. 31:S344
Autor:
Jean Paul Atallah, Tusneem Elhassan, Ahmed Gad, Mashari J Alzahrani, Bader I Alshamsan, Maaz Kamal Alata
Publikováno v:
Journal of Clinical Oncology. 38:e18515-e18515
e18515 Background: A wide range of chemotherapeutic agents have demonstrated antitumor activity in patients with recurrent or metastatic Nasopharyngeal Cancers (NPC). These therapeutic agents have different efficacy and toxicity profile. Capecitabine
Autor:
Kausar Suleman, Mashari J Alzahrani, Naela Agha, Tusneem Elhassan, Adher Al-Sayed, Dahish Ajarim, Marwa I. Abdelgawad, Bader I Alshamsan, Taher Al-Tweigeri
Publikováno v:
Journal of Clinical Oncology. 38:e12602-e12602
e12602 Background: Excess weight is currently recognized as a risk factor for several cancer types, including breast cancer. The primary goal of this study was to evaluate the impact of overweight and obesity in newly diagnosed breast cancer patients